These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27721070)

  • 1. SPR-based assays enable the full functional analysis of bispecific molecules.
    Meschendoerfer W; Gassner C; Lipsmeier F; Regula JT; Moelleken J
    J Pharm Biomed Anal; 2017 Jan; 132():141-147. PubMed ID: 27721070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond conventional dose-response curves: Sensorgram comparison in SPR allows single concentration activity and similarity assessment.
    Gassner C; Karlsson R; Lipsmeier F; Moelleken J
    J Pharm Biomed Anal; 2018 May; 154():57-65. PubMed ID: 29533859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a novel SPR-based assay principle for bispecific molecules.
    Gassner C; Lipsmeier F; Metzger P; Beck H; Schnueriger A; Regula JT; Moelleken J
    J Pharm Biomed Anal; 2015 Jan; 102():144-9. PubMed ID: 25277666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct immobilization of gold-binding antibody fragments for immunosensor applications.
    Ibii T; Kaieda M; Hatakeyama S; Shiotsuka H; Watanabe H; Umetsu M; Kumagai I; Imamura T
    Anal Chem; 2010 May; 82(10):4229-35. PubMed ID: 20415430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical generation of bispecific antibodies.
    Doppalapudi VR; Huang J; Liu D; Jin P; Liu B; Li L; Desharnais J; Hagen C; Levin NJ; Shields MJ; Parish M; Murphy RE; Del Rosario J; Oates BD; Lai JY; Matin MJ; Ainekulu Z; Bhat A; Bradshaw CW; Woodnutt G; Lerner RA; Lappe RW
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22611-6. PubMed ID: 21149738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent kinetic binding model to surface plasmon resonance studies of antigen-antibody displacement reactions.
    Gelinsky-Wersing D; Wersing W; Pompe W
    Anal Biochem; 2017 Feb; 518():110-125. PubMed ID: 27888099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface plasmon resonance biosensing.
    Piliarik M; Vaisocherová H; Homola J
    Methods Mol Biol; 2009; 503():65-88. PubMed ID: 19151937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunodepletion procedure advances free angiopoietin-2 determination in human plasma samples during anti-cancer therapy with bispecific anti-Ang2/VEGF CrossMab.
    Stubenrauch K; Wessels U; Essig U; Vogel R; Waltenberger H; Hansbauer A; Koehler A; Heinrich J
    J Pharm Biomed Anal; 2015 Jan; 102():459-67. PubMed ID: 25459946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Two-in-One" approach for bioassay selection for dual specificity antibodies.
    Lee HY; Schaefer G; Lesaca I; Lee CV; Wong PY; Jiang G
    J Immunol Methods; 2017 Sep; 448():74-79. PubMed ID: 28579366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics.
    Asano R; Shimomura I; Konno S; Ito A; Masakari Y; Orimo R; Taki S; Arai K; Ogata H; Okada M; Furumoto S; Onitsuka M; Omasa T; Hayashi H; Katayose Y; Unno M; Kudo T; Umetsu M; Kumagai I
    MAbs; 2014; 6(5):1243-54. PubMed ID: 25517309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19(+) tumor cells.
    Reusch U; Duell J; Ellwanger K; Herbrecht C; Knackmuss SH; Fucek I; Eser M; McAleese F; Molkenthin V; Gall FL; Topp M; Little M; Zhukovsky EA
    MAbs; 2015; 7(3):584-604. PubMed ID: 25875246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of biosensor-based SPR technology for biological quantification and quality control of pharmaceutical proteins.
    Wang H; Shi J; Wang Y; Cai K; Wang Q; Hou X; Guo W; Zhang F
    J Pharm Biomed Anal; 2009 Dec; 50(5):1026-9. PubMed ID: 19556093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and applications of surface plasmon resonance-based von Willebrand factor-collagen binding assay.
    Saenko E; Kannicht C; Loster K; Sarafanov A; Khrenov A; Kouiavskaia D; Shima M; Ananyeva N; Schwinn H; Gruber G; Josic D
    Anal Biochem; 2002 Mar; 302(2):252-62. PubMed ID: 11878805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development and validation of a sensitive, dual-flow cell, SPR-based biosensor immunoassay for the detection, semi-quantitation, and characterization of antibodies to darbepoetin alfa and epoetin alfa in human serum.
    Mytych DT; La S; Barger T; Ferbas J; Swanson SJ
    J Pharm Biomed Anal; 2009 Feb; 49(2):415-26. PubMed ID: 19135328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interference.
    Weeraratne DK; Lofgren J; Dinnogen S; Swanson SJ; Zhong ZD
    J Immunol Methods; 2013 Oct; 396(1-2):44-55. PubMed ID: 23933325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
    Gu J; Ghayur T
    Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation.
    Shen Y; Zeng L; Novosyadlyy R; Forest A; Zhu A; Korytko A; Zhang H; Eastman SW; Topper M; Hindi S; Covino N; Persaud K; Kang Y; Burtrum D; Surguladze D; Prewett M; Chintharlapalli S; Wroblewski VJ; Shen J; Balderes P; Zhu Z; Snavely M; Ludwig DL
    MAbs; 2015; 7(5):931-45. PubMed ID: 26073904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sensitivity of SPR assays in plasma through efficient parallel assay optimization.
    Moberg A; Lager A; Hämäläinen MD; Jarhede T
    J Pharm Biomed Anal; 2013 May; 78-79():224-32. PubMed ID: 23501443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in surface plasmon resonance based techniques for bioanalysis.
    Phillips KS; Cheng Q
    Anal Bioanal Chem; 2007 Mar; 387(5):1831-40. PubMed ID: 17203259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.